克里唑蒂尼
间变性淋巴瘤激酶
医学
肺癌
基因
癌症研究
肿瘤科
融合基因
遗传学
生物
恶性胸腔积液
作者
Bei Wang,Rongrong Chen,Changxi Wang,Huang Chen,Dingrong Zhong
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2021-01-13
卷期号:153: 176-178
被引量:3
标识
DOI:10.1016/j.lungcan.2021.01.002
摘要
Anaplastic lymphoma kinase (ALK) rearrangements define a molecular subset of non-small cell lung cancer (NSCLC) that generally responds well to ALK tyrosine kinase inhibitors [ [1] Kwak E.L. Bang Y.J. Camidge D.R. Shaw A.T. Solomon B. Maki R.G. Ou S.H. Dezube B.J. Janne P.A. Costa D.B. Varella-Garcia M. Kim W.H. Lynch T.J. Fidias P. Stubbs H. Engelman J.A. Sequist L.V. Tan W. Gandhi L. Mino-Kenudson M. Wei G.C. Shreeve S.M. Ratain M.J. Settleman J. Christensen J.G. Haber D.A. Wilner K. Salgia R. Shapiro G.I. Clark J.W. Iafrate A.J. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N. Engl. J. Med. 2010; 363: 1693-1703 Crossref PubMed Scopus (3607) Google Scholar ]. Since the identification of echinoderm microtubule-associated protein-like 4 (EML4)-ALK fusion in 2007 [ [2] Mano H. Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer. Cancer Sci. 2008; 99: 2349-2355 Crossref PubMed Scopus (186) Google Scholar ], many other fusion partners of ALK in NSCLC have been reported [ 3 Fang D.D. Zhang B. Gu Q. Lira M. Xu Q. Sun H. Qian M. Sheng W. Ozeck M. Wang Z. Zhang C. Chen X. Chen K.X. Li J. Chen S.H. Christensen J. Mao M. Chan C.C. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib. J. Thorac. Oncol. 2014; 9: 285-294 Abstract Full Text Full Text PDF PubMed Scopus (61) Google Scholar , 4 Hou X. Xu H. Chen L. SRBD1-ALK, a novel ALK fusion gene identified in an adenocarcinoma patient by next-generation sequencing. J. Thorac. Oncol. 2019; 14: e72-e73 Abstract Full Text Full Text PDF PubMed Scopus (8) Google Scholar , 5 Qian H. Li J. Zou L. Ji C. Li H. Zheng Y. Guo L. Zhu W. Zhang Y. LTBP1-ALK: a novel fusion identified in malignant pleural effusions from a patient with advanced lung adenocarcinoma. Lung Cancer. 2020; 144: 93-97 Abstract Full Text Full Text PDF PubMed Scopus (2) Google Scholar , 6 Ma L. Zhang Q. Dong Y. Li H. Wang J. SPECC1L-ALK: a novel gene fusion response to ALK inhibitors in non-small cell lung cancer. Lung Cancer. 2020; 143: 97-100 Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar ] in about 2 %–7 % of all NSCLC patients. ALK fusions are currently identified by immunohistochemistry (IHC) (VENTANA D5F3) or reverse transcription-polymerase chain reaction (RT-PCR) in most laboratories. Herein, we employed hybridization-based next-generation sequencing (NGS) of RNA and DNA after IHC and reported a case of adenocarcinoma harboring a novel head-to-head phospholipase B1 (PLB1)-ALK fusion gene.
科研通智能强力驱动
Strongly Powered by AbleSci AI